reports
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc 15-Jan-2024 / 13:46 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc 12-Jan-2024 / 13:37 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc 11-Jan-2024 / 14:15 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc 10-Jan-2024 / 13:33 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc 09-Jan-2024 / 13:35 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc 08-Jan-2024 / 13:46 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc 05-Jan-2024 / 13:39 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc 04-Jan-2024 / 13:27 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc 03-Jan-2024 / 14:01 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc 29-Dec-2023 / 13:33 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc 28-Dec-2023 / 13:19 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc 22-Dec-2023 / 14:27 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC 21-Dec-2023 / 14:16 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC 20-Dec-2023 / 13:45 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC 19-Dec-2023 / 14:22 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC 18-Dec-2023 / 14:57 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc 15-Dec-2023 / 13:46 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals PLC 14-Dec-2023 / 14:07 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc 12-Dec-2023 / 13:50 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc
The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Dechra Pharmaceuticals plc 11-Dec-2023 / 13:41 GMT/BST FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the t...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.